$7.370
-0.361 (-4.90%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AKTX por análisis de gráficos similares
Alphio's AKTX stock price prediction model matches the current Akari Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.35 (-0.26%). The 1-week path is $7.37 (+0.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Akari Therapeutics PLC?
Currently, Akari Therapeutics PLC (AKTX) is not a good buy. The stock is trading at $7.37, significantly below its 52-week high of $29.32, indicating a substantial decline of 70.66% over the past year. The RSI is at 38.906, suggesting it is nearing oversold territory but not yet a strong buy signal. Furthermore, the forward P/E is 0, reflecting no earnings expected in the near term, which raises concerns about its profitability and financial health. The main risk is the negative net income, which reached -14,455,000 USD in Q1 2026, indicating ongoing financial struggles.
AKTX cerró en $7.37 el Friday, tras bajar -4.90%
Akari Therapeutics PLC (AKTX) last closed at $7.3701, losing -4.90%. These facts feed the 1-day and 1-week AKTX price prediction above.
Consenso de analistas
Akari Therapeutics PLC (AKTX): 2 comprar, 1 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Akari Therapeutics PLC (AKTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AKTX, ordenadas por similitud.
Análisis de estacionalidad de AKTX
Historically the probability of a positive November return for AKTX is 0.00%. June offers the highest probability of a positive month at 50.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AKTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.90 | $1.01 | $1.23 | -86.32% |
| Dec 2026 | $1.21 | $1.24 | $1.46 | -83.24% |
En 2026, se proyecta que Akari Therapeutics PLC (AKTX) oscile entre $0.90 y $1.46.
Previsión mensual de Akari Therapeutics PLC para 2026
En Nov de 2026, se proyecta que Akari Therapeutics PLC promedie $1.01, con un mínimo de $0.90 y un máximo de $1.23.
En Dec de 2026, se proyecta que Akari Therapeutics PLC promedie $1.24, con un mínimo de $1.21 y un máximo de $1.46.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.